IL13-PE38QQR cytotoxin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL13-PE38QQR cytotoxin, covering 2014-11-14 to 2014-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma [Phase 1, Phase 2]